Abstract
Rabies is a significant neglected vaccine-preventable disease that is global in distribution. Multiple biologics are utilized in routine prevention and control of this zoonosis. Currently, rabies vaccines are used to interrupt a productive viral encephalitis before or after pathogen exposure in humans and animals. In addition, rabies immune globulins are used as part of prophylaxis after human exposure to a known or suspect animal. Such rabid animals are diagnosed based upon antigenic detection in the brain by selective antibody conjugates. Although experimental proof of concept has been demonstrated in a variety of systems, to date no plant-produced biologics have been licensed for such applicationsĀ in rabies surveillance, prevention or control. In addition, given the breadth of the host spectrum, there are multiple domestic and wild mammalian species that lack specific vaccines and the cross reactivity of existing products is limited by considerable viral diversity. Hence, if safe, effective and inexpensive biologics may be produced in plants, especially for oral delivery, there is a considerable global niche to fill within the realms of public health, veterinary medicine and conservation biology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abelseth MK (1964) An attenuated rabies vaccine for domestic animals produced in tissue culture. Can Vet J 5(11):279ā286
Advisory Committee on Immunization Practices (ACIP) (2008) Human rabies preventionāUnited States, 2008: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2008 May 23;57(RR-3):1ā28
Ahmad A, Singh CK (2016) Comparison of rapid immunodiagnosis assay kit with molecular and immunopathological approaches for diagnosis of rabies in cattle. Vet World 9(1):107ā112
Anderson A, Shwiff S, Gebhardt K, RamĆrez AJ, Shwiff S, Kohler D, Lecuona L (2014) Economic evaluation of vampire bat (Desmodus rotundus) rabies prevention in Mexico. Transbound Emerg Dis 61(2):140ā146
Annand EJ, Reid PA (2014) Clinical review of two fatal equine cases of infection with the insectivorous bat strain of Australian bat lyssavirus. Aust Vet J 92(9):324ā332
ArĆ©chiga Ceballos N, VĆ”zquez MorĆ³n S, Berciano JM, NicolĆ”s O, Aznar LĆ³pez C, Juste J, RodrĆguez Nevado C, Aguilar SetiĆ©n A, EchevarrĆa JE (2013) Novel lyssavirus in bat. Spain Emerg Infect Dis 19(5):793ā795
Asgary V, Shoari A, Baghbani-Arani F, Sadat Shandiz SA, Khosravy MS, Janani A, Bigdeli R, Bashar R, Cohan RA (2016) Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine. Int J Nanomedicine 29(11):3597ā3605
Ashraf S, Singh PK, Yadav DK, Shahnawaz M, Mishra S, Sawant SV, Tuli R (2005) High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J Biotechnol 119(1):1ā4
Aspden K, van Dijk AA, Bingham J, Cox D, Passmore JA, Williamson AL (2002) Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle. Vaccine 20(21ā22):2693ā2701
Astray RM, Jorge SA, Pereira CA (2017) Rabies vaccine development by expression of recombinant viral glycoprotein. Arch Virol 162(2):323ā332
Baby J, Mani RS, Abraham SS, Thankappan AT, Pillai PM, Anand AM, Madhusudana SN, Ramachandran J, Sreekumar S (2015) Natural rabies infection in a domestic fowl (Gallus domesticus): a report from India. PLoS Negl Trop Dis. 9(7):e0003942
Banyard AC, Evans JS, Luo TR, Fooks AR (2014) Lyssaviruses and bats: emergence and zoonotic threat. Viruses 6(8):2974ā2990
BĆ”rcenas-Reyes I, Loza-Rubio E, Zendejas-MartĆnez H, Luna-Soria H, CantĆ³-AlarcĆ³n GJ, MiliĆ”n-Suazo F (2015) Epidemiological trends in bovine paralytic rabies in central Mexico, 2001ā2013. Rev Panam Salud Publica 38(5):396ā402
Barnard BJ (1979) Symptoms of rabies in pets and domestic animals in South Africa and South West Africa. J S Afr Vet Assoc 50(2):109ā111
Basheer AM, Ramakrishna J, Manickam R (1997) Evaluation of post-exposure vaccination against rabies in cattle. New Microbiol 20(3):289ā294
Bassuino DM, Konradt G, Cruz RA, Silva GS, Gomes DC, Pavarini SP, Driemeier D (2016) Characterization of spinal cord lesions in cattle and horses with rabies: the importance of correct sampling. J Vet Diagn Invest 28(4):455ā460
Begeman L, GeurtsvanKessel C, Finke S, Freuling CM, Koopmans M, MĆ¼ller T, Ruigrok TJH, Kuiken T (2017) Comparative pathogenesis of rabies in bats and carnivores, and implications for spillover to humans. Lancet Infect Dis 2017 Oct 31. pii: S1473ā3099(17)30574-1
Bell JF, Moore GJ (1979) Allergic encephalitis, rabies antibodies, and the blood/brain barrier. J Lab Clin Med 94(1):5ā11
Ben Khalifa Y, Luco S, Besson B, Sonthonnax F, Archambaud M, Grimes JM, Larrous F, Bourhy H (2016) The matrix protein of rabies virus binds to RelAp43 to modulate NF-ĪŗB-dependent gene expression related to innate immunity. Sci Rep. 21(6):39420
Benmaamar R, Astray RM, Wagner R, Pereira CA (2009) High-level expression of rabies virus glycoprotein with the RNA-based Semliki forest virus expression vector. J Biotechnol 139(4):283ā290
Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F (1991) Antigenicity of rabies virus glycoprotein. J Virol 65(8):4198ā4203
Bingham J, van der Merwe M (2002) Distribution of rabies antigen in infected brain material: determining the reliability of different regions of the brain for the rabies fluorescent antibody test. J Virol Methods 101(1ā2):85ā94
Biswas S, Reddy GS, Srinivasan VA, Rangarajan PN (2001) Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Hum Gene Ther 12(15):1917ā1922
Blancou J, Baltazar RS, Molli I, Stoltz JF (1991) Effective postexposure treatment of rabies-infected sheep with rabies immune globulin and vaccine. Vaccine 9(6):432ā437
Boland TA, McGuone D, Jindal J, Rocha M, Cumming M, Rupprecht CE, Barbosa TF, de Novaes Oliveira R, Chu CJ, Cole AJ, Kotait I, Kuzmina NA, Yager PA, Kuzmin IV, Hedley-Whyte ET, Brown CM, Rosenthal ES (2014) Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies. Ann Neurol 75(1):155ā160
Both L, Banyard AC, van Dolleweerd C, Horton DL, Ma JK, Fooks AR (2012) Passive immunity in the prevention of rabies. Lancet Infect Dis 12(5):397ā407
Both L, van Dolleweerd C, Wright E, Banyard AC, Bulmer-Thomas B, Selden D, Altmann F, Fooks AR, Ma JK (2013) Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. FASEB J 27(5):2055ā2065
Brito MG, Chamone TL, da Silva FJ, Wada MY, Miranda AB, Castilho JG, Carrieri ML, Kotait I, Lemos FL (2011) Antemortem diagnosis of human rabies in a veterinarian infected when handling a herbivore in Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo. 2011 JanāFeb; 53(1):39ā44
Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR (2005) Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine. 2005 Jul 14; 23(32):4101ā4109
Carneiro V (1954) Transmission of rabies by bats in Latin America. Bull World Health Organ 10(5):775ā780
Centers for Disease Control (CDC) (1983) Exposure to a rabid cowāPennsylvania. Morb Mortal Wkly Rep. 1983 Mar 11; 32(9):128ā129
Centers for Disease Control and Prevention (CDC) (1999) Mass treatment of humans who drank unpasteurized milk from rabid cowsāMassachusetts, 1996ā1998. Morb Mortal Wkly Rep. 1999 Mar 26; 48(11):228ā229
Chang SS, Tsai HJ, Chang FY, Lee TS, Huang KC, Fang KY, Wallace RM, Inoue S, Fei CY (2016) Government response to the discovery of a rabies virus reservoir species on a previously designated rabies-free island, Taiwan, 1999ā2014. Zoonoses Public Health 63(5):396ā402
Charlier J, Forbes A, Van Gucht S, Duchateau L, Goddeeris BM, Vercruysse J (2013) Serological evidence of Ostertagia ostertagi infection in dairy cows does not impact the efficacy of rabies vaccination during the housing period. Res Vet Sci 95(3):1055ā1058
Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 11(5):479ā493
Conzelmann KK, Cox JH, Schneider LG, Thiel HJ (1990) Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175(2):485ā499
Cox JH, Dietzschold B, Schneider LG (1977) Rabies virus glycoprotein II. Biological and serological characterization. Infect Immun. 1977 Jun; 16(3):754ā759
da Cruz FW, McBride AJ, ConceiĆ§Ć£o FR, Dale JW, McFadden J, Dellagostin OA (2001) Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. Vaccine 20(5):731ā736
de Kruif J, Bakker AB, Marissen WE, Kramer RA, Throsby M, Rupprecht CE, Goudsmit J (2007) A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis. Annu Rev Med 18(58):359ā368
de Macedo Pessoa CR, Cristiny Rodrigues Silva ML, de Barros Gomes AA, Isabel EstĆ©vez Garcia A, Honma Ito F, Eduardo BrandĆ£o P, Riet-Correa F (2011) Paralytic rabies in swine. Braz J Microbiol 42(1):298ā302
Den K, Sato T, Schneebeli M, Morita Y (2012) Acoustic characteristics of voiceless bellowing typical of bovine rabies. Am J Trop Med Hyg 86(3):528ā530
Dertzbaugh MT, Elson CO (1993) Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Infect Immun 61(1):48ā55
Devleesschauwer B, Aryal A, Sharma BK, Ale A, Declercq A, Depraz S, Gaire TN, Gongal G, Karki S, Pandey BD, Pun SB, Duchateau L, Dorny P, Speybroeck N (2016) Epidemiology, impact and control of rabies in Nepal: a systematic review. PLoS Negl Trop Dis. 10(2):e0004461
Dietzschold B, Wang HH, Rupprecht CE, Celis E, Tollis M, Ertl H, Heber-Katz E, Koprowski H (1987) Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci U S A. 84(24):9165ā9169
Dietzschold B, Gore M, Marchadier D, Niu HS, Bunschoten HM, Otvos L, Wunner WH, Ertl HC, Osterhaus AD, Koprowski H (1990) Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J Virol 64(8):3804ā3809
Dietzschold B, Li J, Faber M, Schnell M (2008) Concepts in the pathogenesis of rabies. Future Virol 3(5):481ā490
Drake PM, Szeto TH, Paul MJ, Teh AY, Ma JK (2017) Recombinant biologic products versus nutraceuticals from plantsāa regulatory choice? Br J Clin Pharmacol 83(1):82ā87
Eggerbauer E, de Benedictis P, Hoffmann B, Mettenleiter TC, Schlottau K, Ngoepe EC, Sabeta CT, Freuling CM, MĆ¼ller T (2016) Evaluation of six commercially available rapid immunochromatographic tests for the diagnosis of rabies in brain material. PLoS Negl Trop Dis. 10(6):e0004776
Ertl HC (2009) Novel vaccines to human rabies. PLoS Negl Trop Dis. 3(9):e515
Ertl HC, Dietzschold B, Gore M, Otvos L Jr, Larson JK, Wunner WH, Koprowski H (1989) Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. J Virol 63(7):2885ā2892
European Medicines Agency (2016) Guideline on the quality of biological active substances produced by stable transgene expression in higher plants [online]. Available at www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003154.pdf. Last accessed 29 June 2016
Favre H, Valette L, PrĆ©causta P, Roulet C, Brun A, TerrĆ© J, Fontaine J, Stellmann C (1976) Anti-foot-and-mouth vaccines combined with other bacterial or viral vaccines. Dev Biol Stand 35:409ā428
Fehlner-Gardiner C, Nadin-Davis S, Armstrong J, Muldoon F, Bachmann P, Wandeler A (2008) Era vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989ā2004. J Wildl Dis 44(1):71ā85
Fekadu M (1982) Rabies in Ethiopia. Am J Epidemiol 115(2):266ā273
Fekadu M, Shaddock JH, Baer GM (1982) Excretion of rabies virus in the saliva of dogs. J Infect Dis 145(5):715ā719
Feng Y, Shi Y, Yu M, Xu W, Gong W, Tu Z, Ding L, He B, Guo H, Tu C (2016) Livestock rabies outbreaks in Shanxi province. China Arch Virol 161(10):2851ā2854
Fernando BG, Yersin CT, JosƩ CB, Paola ZS (2016) Predicted 3D model of the rabies virus glycoprotein trimer. Biomed Res Int 2016:1674580
Filho OA, Megid J, Geronutti L, Ratti J Jr, Almeida MFA, Kataoka APAG, Martorelli LFA (2012) Vaccine immune response and interference of colostral antibodies in calves vaccinated against rabies at 2, 4 and 6 months of age born from antirabies revaccinated females. Res Vet Sci 92(3):396ā400
Fitzpatrick JL, Dyer JL, Blanton JD, Kuzmin IV, Rupprecht CE (2014) Rabies in rodents and lagomorphs in the United States, 1995ā2010. J Am Vet Med Assoc 245(3):333ā337
Foley HD, McGettigan JP, Siler CA, Dietzschold B, Schnell MJ (2000) A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc Natl Acad Sci USA. 2000 Dec19; 97(26):14680ā14685
Fontaine J, Favre H, Valette L, PrĆ©causta P, Roulet C, Brun A, TerrĆ© J (1976) Combined vaccines including 1 or several anti-foot-and-mouth valences. Dev Biol Stand 35:395ā407
Fontana D, Etcheverrigaray M, Kratje R, Prieto C (2016) Development of rabies virus-like particles for vaccine applications: production, characterization, and protection studies. Methods Mol Biol 1403:155ā166
Fooks AR, Brookes SM, Johnson N, McElhinney LM, Hutson AM (2003) European bat lyssaviruses: an emerging zoonosis. Epidemiol Infect 131(3):1029ā1039
Forthal Donald N, Gach Johannes S, Landucci Gary, Jez Jakub, Strasser Richard, Kunert Renate, Steinkellner Herta (2010) Fc-glycosylation influences FcĪ³ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J Immunol 185:6876ā6882
Fry TL, Vandalen KK, Duncan C, Vercauteren K (2013) The safety of ONRABĀ® in select non-target wildlife. Vaccine 31(37):3839ā3842
Fuenzalida E, DĆaz AM, Rivenson S (1978) Suckling mouse brain rabies vaccine supplemented with an adjuvant. Its use in cattle. Rev Asoc Argent Microbiol. 1978 MayāAug; 10(2):47ā53
Gadaga BM, Etter EM, Mukamuri B, Makwangudze KJ, Pfukenyi DM, Matope G (2016) Living at the edge of an interface area in Zimbabwe: cattle owners, commodity chain and health workersā awareness, perceptions and practices on zoonoses. BMC Public Health 16(1):84
Gautret P, Lim PL, Shaw M, Leder K (2011) Rabies post-exposure prophylaxis in travellers returning from Bali, Indonesia, November 2008 to March 2010. Clin Microbiol Infect 17(3):445ā447
Gibson AD, Handel IG, Shervell K, Roux T, Mayer D, Muyila S, Maruwo GB, Nkhulungo EM, Foster RA, Chikungwa P, Chimera B, Bronsvoort BM, Mellanby RJ, Gamble L (2016) The vaccination of 35,000 dogs in 20 working days using combined static point and door-to-door methods in Blantyre, Malawi. PLoS Negl Trop Dis 10(7):e0004824
Gigante CM, Dettinger L, Powell JW, Seiders M, Condori REC, Griesser R, Okogi K, Carlos M, Pesko K, Breckenridge M, Simon EMM, Chu MYJV, Davis AD, Brunt SJ, Orciari L, Yager P, Carson WC, Hartloge C, Saliki JT, Sanchez S, Deldari M, Hsieh K, Wadhwa A, Wilkins K, Peredo VY, Rabideau P, Gruhn N, Cadet R, Isloor S, Nath SS, Joseph T, Gao J, Wallace R, Reynolds M, Olson VA, Li Y, Kalendar R (2018) Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics. PLOS ONE 13(5):e0197074
Gilbert A, Greenberg L, Moran D, Alvarez D, Alvarado M, Garcia DL, Peruski L (2015) Antibody response of cattle to vaccination with commercial modified live rabies vaccines in Guatemala. Prev Vet Med 118(1):36ā44
Gnanadurai CW, Zhou M, He W, Leyson CM, Huang CT, Salyards G, Harvey SB, Chen Z, He B, Yang Y, Hooper DC, Dietzchold B, Fu ZF (2013) Presence of virus neutralizing antibodies in cerebral spinal fluid correlates with non-lethal rabies in dogs. PLoS Negl Trop Dis 7(9):e2375
Gomme EA, Wanjalla CN, Wirblich C, Schnell MJ (2011) Rabies virus as a research tool and viral vaccine vector. Adv Virus Res 79:139ā164
Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, de Kruif J, Dietzschold B, Bakker AB, Rupprecht CE (2006) Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J Infect Dis 193(6):796ā801
GrƤni R, Wandeler A, Steck F, Rƶsli R (1978) Rabies in a veterinarian. Schweiz MedWochenschr 108(16):593ā597
Greenhall AM, Schmidt U (eds) (1988) The natural history of vampire bats. CRC Press, Boca Raton, Fl
Gunawardena PS, Marston DA, Ellis RJ, Wise EL, Karawita AC, Breed AC, McElhinney LM, Johnson N, Banyard AC, Fooks AR (2016) Lyssavirus in Indian Flying Foxes, Sri Lanka. Emerg Infect Dis 22(8):1456ā1459
Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, Costa P, Freuling CM, Hiby E, Knopf L, Leanes F, Meslin FX, Metlin A, Miranda ME, MĆ¼ller T, Nel LH, Recuenco S, Rupprecht CE, Schumacher C, Taylor L, Vigilato MA, Zinsstag J, Dushoff J (2015) Global alliance for rabies control partners for rabies prevention. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis 9(4):e0003709
Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714
Hartmann K, Day MJ, Thiry E, Lloret A, Frymus T, Addie D, Boucraut-Baralon C, Egberink H, Gruffydd-Jones T, Horzinek MC, Hosie MJ, Lutz H, Marsilio F, Pennisi MG, Radford AD, Truyen U, Mƶstl K (2015) European advisory board on cat diseases. Feline injection-site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg 17(7):606ā613
Harvey AM, Watson JL, Brault SA, Edman JM, Moore SM, Kass PH, Wilson WD (2016) Duration of serum antibody response to rabies vaccination in horses. J Am Vet Med Assoc 249(4):411ā418
Hayman DT, Fooks AR, Rowcliffe JM, McCrea R, Restif O, Baker KS, Horton DL, Suu-Ire R, Cunningham AA, Wood JL (2012) Endemic Lagos bat virus infection in Eidolon helvum. Epidemiol Infect 140(12):2163ā2171
Hermann JR, Fry AM, Siev D, Slate D, Lewis C, Gatewood DM (2011) Stability of vaccinia-vectored recombinant oral rabies vaccine under field conditions: a 3-year study. Can J Vet Res 75(4):278ā284
Hermann J, Fry A, Reising M, Patterson P, Siev D, Gatewood D (2012) Rabies vaccine standards: comparison of the 5th and 6th WHO international reference standards to the USDA veterinary reference standard. Vaccine 30(48):6892ā6896
Hiatt A, Bohorova N, Bohorov O, Goodman C, Kim D, Pauly MH, Velasco J et al (2014) Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc Natl Acad Sci USA 111:5992ā5997
Hicks DJ, Fooks AR, Johnson N (2012) Developments in rabies vaccines. Clin Exp Immunol 169(3):199ā204
Hƶper D, Freuling CM, MĆ¼ller T, Hanke D, von Messling V, Duchow K, Beer M, Mettenleiter TC (2015) High definition viral vaccine strain identity and stability testing using full-genome population dataāthe next generation of vaccine quality control. Vaccine 33(43):5829ā5837
Horton DL, Banyard AC, Marston DA, Wise E, Selden D, Nunez A, Hicks D, Lembo T, Cleaveland S, Peel AJ, Kuzmin IV, Rupprecht CE, Fooks AR (2014) Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus. J GenVirol 95(Pt 5):1025ā1032
Hostnik P, Picard-Meyer E, RihtariÄ D, Toplak I, Cliquet F (2014) Vaccine-induced rabies in a red fox (Vulpes vulpes): isolation of vaccine virus in brain tissue and salivary glands. J Wildl Dis 50(2):397ā401
Hu SC, Hsu CL, Lee MS, Tu YC, Chang JC, Wu CH, Lee SH, Ting LJ, Tsai KR, Cheng MC, Tu WJ, Hsu WC (2018) Lyssavirus in Japanese Pipistrelle, Taiwan. Emerg Infect Dis 24(4):782ā785
Hudson LC, Weinstock D, Jordan T, Bold-Fletcher NO (1996a) Clinical features of experimentally induced rabies in cattle and sheep. Zentralbl Veterinarmed B 43(2):85ā95
Hudson LC, Weinstock D, Jordan T, Bold-Fletcher NO (1996b) Clinical presentation of experimentally induced rabies in horses. Zentralbl Veterinarmed B 43(5):277ā285
Hundal JS, Sodhi SS, Gupta A, Singh J, Chahal US (2016) Awareness, knowledge, and risks of zoonotic diseases among livestock farmers in Punjab. Vet World 9(2):186ā191
Hutter SE, Brugger K, Sancho Vargas VH, GonzĆ”lez R, Aguilar O, LeĆ³n B, Tichy A, Firth CL, Rubel F (2016) Rabies in Costa Rica: documentation of the surveillance program and the endemic situation from 1985 to 2014. Vector Borne Zoonotic Dis 16(5):334ā341
Jiang Y, Yu X, Wang L, Lu Z, Liu H, Xuan H, Hu Z, Tu C (2008) An outbreak of pig rabies in Hunan province, China. Epidemiol Infect 136(4):504ā508
Johnson N, Cunningham AF, Fooks AR (2010) The immune response to rabies virus infection and vaccination. Vaccine 28(23):3896ā3901
Johnson N, ArĆ©chiga-Ceballos N, Aguilar-Setien A (2014) Vampire bat rabies: ecology, epidemiology and control. Viruses 6(5):1911ā1928
Juarez P, Virdi V, Depicker A, Orzaez D (2016) Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications. Plant biotechnol J. 2016 Feb 1
Kang H, Qi Y, Wang H, Zheng X, Gao Y, Li N, Yang S, Xia X (2015) Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Viruses 7:1134ā1152
Kgaladi J, Wright N, Coertse J, Markotter W, Marston D, Fooks AR, Freuling CM, MĆ¼ller TF, Sabeta CT, Nel LH (2013) Diversity and epidemiology of Mokola virus. PLoS Negl Trop Dis. 7(10):e2511
Klepfer SR, Debouck C, Uffelman J, Jacobs P, Bollen A, Jones EV (1993) Characterization of rabies glycoprotein expressed in yeast. Arch Virol 128(3ā4):269ā286
Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A 100(13):8013ā8018
Koraka P, Bosch BJ, Cox M, Chubet R, Amerongen GV, Lƶvgren-Bengtsson K, Martina BE, Roose J, Rottier PJ, Osterhaus AD (2014) A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Vaccine. 2014 Aug 6; 32(36):4644ā4650
Korns RF, Zeissig A (1948) Dog, fox, and cattle rabies in New York State; evaluation of vaccination in dogs. Am J Publ Hlth Nations Hlth. 1948 Jan; 38(1 Pt1):50ā65
Kristina LE, Luthar Z (2016) Production of vaccines for treatment of infectious diseases by transgenic plants. Acta agriculturae Slovenica. 2016 Apr 6; 107(1):191ā217
Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1(5):398ā401
Kushnir N, Streatfield SJ, Yusibov V (2012) Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31(1):58ā83
Kuzmin IV, Hughes GJ, Botvinkin AD, Orciari LA, Rupprecht CE (2005) Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res 111(1):28ā43
Kuzmin IV, Wu X, Tordo N, Rupprecht CE (2008) Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions. Virus Res 136(1ā2):81ā90
Kuzmin IV, Turmelle AS, Agwanda B, Markotter W, Niezgoda M, Breiman RF, Rupprecht CE (2011) Commersonās leaf-nosed bat (Hipposideros commersoni) is the likely reservoir of Shimoni bat virus. Vector Borne Zoonotic Dis 11(11):1465ā1470
Kuzmina NA, Kuzmin IV, Ellison JA, Rupprecht CE (2013) Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein. J Antiviral Antiretrovirals 5:37ā43
Kwon KC, Verma D, Singh ND, Herzog R, Daniell H (2013) Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev 65(6):782ā799
Laere E, Ling AP, Wong YP, Koh RY, Mohd Lila MA, Hussein S (2016) Plant-based vaccines: production and challenges. J Bot. 2016 Apr 13
Lafon M, Wiktor TJ, Macfarlan RI (1983) Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J Gen Virol 64(Pt 4):843ā851
Lafon M, Scott-Algara D, Marche PN, Cazenave PA, Jouvin-Marche E (1994) Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen. J Exp Med 180(4):1207ā1215
Lathe CL (1994) Neospora caninum in British dogs. Vet Rec 134(20):532
Lavan RP, King AI, Sutton DJ, Tunceli K (2017) Rationale and support for a one health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings. Vaccine 35(13):1668ā1674
Lee DN, PapeÅ M, Van den Bussche RA (2012) Present and potential future distribution of common vampire bats in the Americas and the associated risk to cattle. PLoS ONE 7(8):e42466
Lewis CE, Fry AM, Hermann JR, Siev D, Dusek DM, Gatewood DM (2012) Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays. Dev Biol (Basel) 134:29ā33
Li J, Faber M, Dietzschold B, Hooper DC (2011) The role of toll-like receptors in the induction of immune responses during rabies virus infection. Adv Virus Res 79:115ā126
Liu Y, Zhang S, Ma G, Zhang F, Hu R (2008) Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine. Vaccine 26(42):5368ā5372
Liu Y, Zhang S, Zhao J, Zhang F, Hu R (2013) Isolation of Irkut virus from a Murina leucogaster bat in China. PLoS Negl Trop Dis 7(3):e2097
Liu X, Yang Y, Sun Z, Chen J, Ai J, Dun C, Fu ZF, Niu X, Guo X (2014) A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge. PLoS ONE 9(2):e87105
Liu Y, Zhang HP, Zhang SF, Wang JX, Zhou HN, Zhang F, Wang YM, Ma L, Li N, Hu RL (2016) Rabies outbreaks and vaccination in domestic camels and cattle in northwest China. PLoS Negl Trop Dis 10(9):e0004890
Lodmell DL, Esposito JJ, Ewalt LC (2004) Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Vaccine 22(25):3329ā3333
Lord RD, Fuenzalida E, Delpietro H, Larghi OP, de DĆaz AM, LĆ”zaro L (1975) Observations on the epizootiology of vampire bat rabies. Bull Pan Am Health Organ 9(3):189ā195
Loza-Rubio E, Rojas-Anaya E, LĆ³pez J, Olivera-Flores MT, GĆ³mez-Lim M, Tapia-PĆ©rez G (2012) Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Vaccine 30(37):5551ā5556
Lycke N, Bromander AK, Holmgren J (1989) Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge. Int Arch Allergy Immunol 88(3):273ā279
Macfarlan RI, Dietzschold B, Wiktor TJ, Kiel M, Houghten R, Lerner RA, Sutcliffe JG, Koprowski H (1984) T cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. J Immunol. 133(5):2748ā2752
Madhusudana SN, Subha S, Thankappan U, Ashwin YB (2012) Evaluation of a direct rapid immunohistochemical test (dRIT) for rapid diagnosis of rabies in animals and humans. Virol Sin 27(5):299ā302
Malek LT, Soostmeyer G, Garvin T, James E (1984) The rabies glycoprotein gene is expressed in Escherichia coli as denatured polypeptide. In: Channock RM, Lerner RA (eds) Modem approaches in vaccines: molecular and chemical basis of virus virulence and immunity. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1:203ā208
Malerczyk C, Briggs DJ, Dreesen DW, Banzhoff A (2007) Duration of immunity: an anamnestic response 14Ā years after rabies vaccination with purified chick embryo cell rabies vaccine. J Travel Med. 2007 JanāFeb; 14(1):63ā64
Malerczyk C, Selhorst T, Tordo N, Moore S, MĆ¼ller T (2009) Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains. Vaccine 27(39):5320ā5325
Mansfield KL, Andrews N, Goharriz H, Goddard T, McElhinney LM, Brown KE, Fooks AR (2016) Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans. Vaccine 34(48):5959ā5967
Marasco WA, Sui J (2007) The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol 25(12):1421ā1434
Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, Jongeneelen M (2005) Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 79(8):4672ā4678
Martin RJ, Schnurrenberger PR, Walker JF (1982) Exposure to rabiesāan occupational hazard for veterinarians. Can Vet J 23(11):317ā322
Mayen F (2003) Haematophagous bats in Brazil, their role in rabies transmission, impact on public health, livestock industry and alternatives to an indiscriminate reduction of bat population. J Vet Med B Infect Dis Vet Public Health 50(10):469ā472
McGarvey PB, Hammond J, Dienelt MM, Hooper DC, Fu ZF, Dietzschold B, Koprowski H, Michaels FH (1995) Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology (NY) 13(13):1484ā1487
McLaughlin K (2016) Scandal clouds Chinaās global vaccine ambitions. Science 352(6285):506
Meltzer MI, Rupprecht CE (1998) A review of the economics of the prevention and control of rabies. Part 2: Rabies in dogs, livestock and wildlife. Pharmacoeconomics 14(5):481ā498
Memish ZA, Assiri AM, Gautret P (2015) Rabies in Saudi Arabia: a need for epidemiological data. Int J Infect Dis 34:99ā101
Miguens L (2007) The opinion of the production sector on the role of vaccines in the control and eradication of livestock diseases in Argentina. Rev Sci Tech. 2007 Aug; 26(2):479ā483, 485ā488
Miller RE, Fowler M (eds) (2012) Zoo and wild animal medicine: current therapy, vol 7. Elsevier, St. Louis, Missouri
Mitmoonpitak C, Limusanno S, Khawplod P, Tepsumethanon V, Wilde H (2002) Post-exposure rabies treatment in pigs. Vaccine 20(16):2019ā2021
Modelska A, Dietzschold B, Sleysh N, Fu ZF, Steplewski K, Hooper DC, Koprowski H, Yusibov V (1998) Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci USA 95(5):2481ā2485
Monaco F, Franchi PM, Lelli R (2006) Studies on an inactivated vaccine against rabies virus in domestic animals. Dev Biol (Basel) 125:233ā239
Monroe BP, Yager P, Blanton J, Birhane MG, Wadhwa A, Orciari L, Petersen B, Wallace R (2016) Rabies surveillance in the United States during 2014. J Am Vet Med Assoc 248(7):777ā788
Moore SM, Wilkerson MJ, Davis RD, Wyatt CR, Briggs DJ (2006) Detection of cellular immunity to rabies antigens in human vaccinees. J Clin Immunol 26(6):533ā545
Moore MC, Davis RD, Kang Q, Vahl CI, Wallace RM, Hanlon CA, Mosier DA (2015) Comparison of anamnestic responses to rabies vaccination in dogs and cats with current and out-of-date vaccination status. J Am Vet Med Assoc. 2015 Jan15; 246(2):205ā211
Morgeaux S, Poirier B, Ragan CI, Wilkinson D, Arabin U, Guinet-Morlot F, Levis R, Meyer H, Riou P, Shaid S, Volokhov D, Tordo N, Chapsal JM (2017) Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISAāResults of an international collaborative study. Vaccine 35(6):966ā971
MorĆ³n G, Rueda P, Casal I, Leclerc C (2002) CD8Ī±2 CD11bā+ādendritic cells present exogenous virus-like particles to CD8ā+āT cells and subsequently express CD8Ī± and CD205 molecules. J Exp Med 195(10):1233ā1245
MĆ¼ller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, Fehlner-Gardiner C, Kliemt J, Meslin FX, Franka R, Rupprecht CE, Tordo N (2009) Correction: development of a mouse monoclonal antibody cocktail for post-exposure rabies Prophylaxis in humans. PLOS Negl Trop Dis 3(11):10ā371
MĆ¼ller T, Freuling CM, Wysocki P, Roumiantzeff M, Freney J, Mettenleiter TC, Vos A (2015) Terrestrial rabies control in the European Union: historical achievements and challenges ahead. Vet J 203(1):10ā17
National Association of State Public Health Veterinarians (NASPHV) (2016) Compendium of animal rabies prevention and control committee, Brown CM, Slavinski S, Ettestad P, Sidwa TJ, Sorhage FE. Compendium of animal rabies prevention and control. J Am Vet Med Assoc. 2016 Mar 1; 248(5):505ā517
Nokireki T, Tammiranta N, Kokkonen UM, Kantala T, Gadd T (2018) Tentative novel lyssavirus in a bat in Finland. Transbound Emerg Dis 65(3):593ā596
Nolden T, Banyard AC, Finke S, Fooks AR, Hanke D, Hƶper D, Horton DL, Mettenleiter TC, MĆ¼ller T, Teifke JP, Freuling CM (2014) Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus. J Gen Virol 95(Pt 8):1647ā1653
Ogino M, Ito N, Sugiyama M, Ogino T (2016) The rabies virus L protein catalyzes mRNA capping with GDP polyribonucleotidyltransferase activity. Viruses. 2016 May 21; 8(5)
Okolo MI (1989) Vaccine-induced rabies infection in rural dogs in Anambra State, Nigeria. Microbios 57(231):105ā112
Ortiz-Prado E, Galarza C, Cornejo LeĆ³n F, Ponce J (2014) Access to drugs and the situation of the pharmaceutical market in Ecuador. Revista Panamericana de Salud PĆŗblica 36(1):57ā62
Palanisamy R, Ramanna BC, Ananda Rao K, Srinivasan VA (1992) Combined vaccination of cattle against FMD and rabies. Microbiologica 15(1):45ā49
Pastoret PP, Vanderplasschen A (2003) Poxviruses as vaccine vectors. Comp Immunol Microbiol Infect Dis 26(5ā6):343ā355
Pawan JL (1959) The transmission of paralytic rabies in Trinidad by the vampire bat (Desmodus rotundus murinus Wagner. Caribb Med J 21:110ā136
PĆ©pin M, Blancou J, Aubert MF (1984) Experimental bovine rabies: susceptibility, symptoms, humoral immunologic reactions, lesions and virus excretion. Ann Rech Vet. 15(3):325ā333
Perea Arango I, Loza Rubio E, Rojas Anaya E, Olivera Flores T, Gonzalez de la Vara L, GĆ³mez Lim MA (2008) Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice. Plant Cell Rep 27(4):677ā685
Petricciani JC, Grachev VP, Sizaret PP, Regan PJ (1989) Vaccines: obstacles and opportunities from discovery to use. Rev Infect Dis. 1989 MayāJun; 11 Suppl 3:S524ā5249
Piza AT, Pieri KM, Lusa GM, Caporale GM, Terreran MT, Machado LA, Zanetti CR (2002) Effect of the contents and form of rabies glycoprotein on the potency of rabies vaccination in cattle. Mem Inst Oswaldo Cruz 97(2):265ā268
Prosniak M, Faber M, Hanlon CA, Rupprecht CE, Hooper DC, Dietzschold B (2003) Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Inf Dis 188(1):53ā56
Quirozr DE, Sutmoeller P, Barroeta M (1964) Factors associated with anaphylactic reactions to chicken embryo foot-and-mouth disease vaccine and Flury Rabies vaccine in cattle of Venezuela. Am J Vet Res 25:1627ā1634
Ramya R, Subramanian BM, Sivakumar V, Senthilkumar RL, Rao KS, Srinivasan VA (2011) Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice. Clin Vaccine Immunol 18(10):1673ā1679
Rappuoli R (2014) Inner Workings: 1885, the first rabies vaccination in humans. Proc Natl Acad Sci USA 111(34):12273
Reculard R (1996) Cell-culture vaccines for veterinary use. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies, 4th edn. WHO, Geneva, pp 314ā323
Robardet E, Picard-Meyer E, DobroÅ”tana M, Jaceviciene I, MƤhar K, Muižniece Z, Pridotkas G, Masiulis M, Niin E, OlÅ”evskis E, Cliquet F (2016) Rabies in the Baltic States: decoding a process of control and elimination. PLoS Negl Trop Dis 10(2):e0004432
Rodrigues da Silva AC, Caporale GM, GonƧalves CA, Targueta MC, Comin F, Zanetti CR, Kotait I (2000) Antibody response in cattle after vaccination with inactivated and attenuated rabies vaccines. Rev Inst Med Trop Sao Paulo. 2000 MarāApr; 42(2):95ā98
Rojas-Anaya E, Loza-Rubio E, Olivera-Flores MT, Gomez-Lim M (2009) Expression of rabies virus G protein in carrots (Daucus carota). Transgenic Res 18:911ā919
Rotz LD, Hensley JA, Rupprecht CE, Childs JE (1998) Large-scale human exposures to rabid or presumed rabid animals in the United States: 22 cases (1990ā1996). J Am Vet Med Assoc 212(8):1198ā1200
Roy S, Mukherjee S, Pawar S, Chowdhary A (2016) Evaluation of in vitro antiviral activity of datura metel Linn. Against Rabies Virus. Pharmacognosy Res. 2016 OctāDec; 8(4):265ā269
Rupprecht CE (2016) Rabies. In: Aiello SE (ed) Merck veterinary manual, 11th edn. Merck Publishing Group, Rahway, NJ, USA, pp 1302ā1306
Rupprecht CE, Burgess GW (2015) Viral and vector zoonotic exploitation of a homo-sociome memetic complex. Clin Microbiol Infect 21(5):394ā403
Rupprecht CE, Dietzschold B (1987) Perspectives on rabies virus pathogenesis. Lab Invest 57(6):603ā606
Rupprecht CE, Kuzmin IV (2015) Why we can prevent, control and possibly treatābut will not eradicate rabies. Future Virol 10(5):517ā535
Rupprecht CE, Turmelle A, Kuzmin IV (2011) A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol 1(6):662ā670
Rupprecht CE, Nagarajan T, Ertl H (2016) Current status and development of vaccines and other biologics for human rabies prevention. Expert Rev Vaccines 15(6):731ā749
Rupprecht C, Kuzmin I, Meslin F (2017) Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies. F1000Res. 2017 Feb 23; 6:184
Schiffelers MJ, Blaauboer B, Bakker W, Hendriksen C (2014) Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers. Biologicals 42(4):205ā217
Schnee M, Vogel AB, Voss D, Petsch B, Baumhof P, Kramps T, Stitz L (2016) An mRNA vaccine encoding rabies virus glycoprotein induces protection against lethal infection in mice and correlates of protection in adult and newborn pigs. PLoS Negl Trop Dis 10(6):e0004746
Scott T, Hasse R, Nel L (2012) Rabies in kudu (Tragelaphus strepsiceros). Berl Munch Tierarztl Wochenschr. 2012 MayāJun; 125(5ā6):236ā241
Shahaid N, Daniell H (2016) Plant based oral vaccines against zoonotic and nonāzoonotic diseases. Plant Biotechnol J. 2016 Jul 1
Shakin-Eshleman SH, Remaley AT, Eshleman JR, Wunner WH, Spitalnik SL (1992) N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression. J Biol Chem 267(15):10690ā10698
Shinwari MW, Annand EJ, Driver L, Warrilow D, Harrower B, Allcock RJ, Pukallus D, Harper J, Bingham J, Kung N, Diallo IS (2014) Australian bat lyssavirus infection in two horses. Vet Microbiol 173(3ā4):224ā231
Sigoillot-Claude C, Battaglio M, Fiorucci M, Gillet D, Vimort AS, Giraud Y, Laurent S, Vaganay A, Poulet H (2015) A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine. Vaccine 33(32):3843ā3849
Sijmon PC, Dekker BMM, Schrammeijer B, Verwoerd TC, van den Elzen PMJ, Hoekema A (1990) Production of correctly processed human serum albumin in transgenic plants. Biotechnology 8:217ā221
Sikes RK (1970) Guidelines for the control of rabies. Am J Publ Hlth, Nations Health 60(6):1133ā1138
Simani S, Fayaz A, Rahimi P, Eslami N, Howeizi N, Biglari P (2012) Six fatal cases of classical rabies virus without biting incidents, Iran 1990ā2010. J Clin Virol 54(3):251ā254
Singh V (1999) Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 30:149ā158
Singh CK, Sandhu BS (2008) Rabies in South Asia: epidemiological investigations and clinical perspective. Dev Biol (Basel) 131:133ā136
Singh A, Srivastava S, Chouksey A, Singh Panwar B, Verma PC, Roy S, Singh PK, Saxena G, Tuli R (2015) Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: a step towards oral vaccination for rabies. Mol Biotechnol 57:359ā370
Slate D, Algeo TP, Nelson KM, Chipman RB, Donovan D, Blanton JD, Niezgoda M, Rupprecht CE (2009) Oral rabies vaccination in North America: opportunities, complexities, and challenges. PLoS Negl Trop Dis. 3(12):e549
Smith CM, Fry SC, Gough KC, Patel AJ, Glenn S, Goldrick M, Roberts IS, Whitelam GC, Andrew PW (2014) Recombinant plants provide a new approach to the production of bacterial polysaccharide for vaccines. PLoS ONE 9(2):e88144
Song H, Zhou L, Fang W, Li Y, Wang X, Fang H, Li X, Wu M, Qiu B (2004) High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha. Biochem Biophys Res Commun 315(1):235ā239
Soulebot JP, PrĆ©causta P, Brun A, Chappuis G, TerrĆ© J, Favre H, Petermann HG (1978) Prevention of animal rabies by an attenuated monovalent or mixed vaccine. Dev Biol Stand 41:389ā399
Starodubova ES, Preobrazhenskaia OV, Kuzmenko YV, Latanova AA, Yarygina EI, Karpov VL (2015) Rabies vaccines: current status and prospects for development. Mol Biol 49(4):513ā519
Stein LT, Rech RR, Harrison L, Brown CC (2010) Immunohistochemical study of rabies virus within the central nervous system of domestic and wildlife species. Vet Pathol 47(4):630ā633
Stoner-Duncan B, Streicker DG, Tedeschi CM (2014) Vampire bats and rabies: toward an ecological solution to a public health problem. PLoS Negl Trop Dis. 2014 Jun19; 8(6):e2867
Strasser R, Stadlmann J, SchƤhs M, Stiegler G, Quendler H, Mach L, Glƶssl J, Weterings K, Pabst M, Steinkellner H (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 6(4):392ā402
Streicker DG, Allgeier JE (2016) Foraging choices of vampire bats in diverse landscapes: potential implications for land-use change and disease transmission. J Appl Ecol 53(4):1280ā1288
Swai ES, Schoonman L, Daborn CJ (2010) Knowledge and attitude towards zoonoses among animal health workers and livestock keepers in Arusha and Tanga, Tanzania. Tanzan J Health Res 12(4):280ā286
Swamy HS, Shankar SK, Chandra PS, Aroor SR, Krishna AS, Perumal VK (1984) Neurological complications due to beta-propiolactone (BPL)-inactivated antirabies vaccination: clinical, electrophysiological and therapeutic aspects. J Neurol Sci 63(1):111ā128
Tariq WU, Shafi MS, Jamal S, Ahmad M (1991) Rabies in man handling infected calf. Lancet 337(8751):1224
Thiptara A, Atwill ER, Kongkaew W, Chomel BB (2011) Epidemiologic trends of rabies in domestic animals in southern Thailand, 1994-2008. Am J Trop Med Hyg 85(1):138ā145
Thompson MK, Fridy PC, Keegan S, Chait BT, Fenyƶ D, Rout MP (2016) Optimizing selection of large animals for antibody production by screening immune response to standard vaccines. J Immunol Methods 430:56ā60
Tian D, Luo Z, Zhou M, Li M, Yu L, Wang C, Yuan J, Li F, Tian B, Sui B, Chen H, Fu ZF, Zhao L (2015) Critical role of K1685 and K1829 in the large protein of rabies virus in viral pathogenicity and immune evasion. J Virol 90(1):232ā244
Topp E, Irwin R, McAllister T, Lessard M, Joensuu JJ, Kolotilin I, Conrad U, Stƶger E, Mor T, Warzecha H, Hall JC (2016) The case for plant-made veterinary immunotherapeutics. Biotechnol Adv 34(5):597ā604
Tsekoa TL, Lotter-Stark T, Buthelezi S, Chakauya E, Stoychev SH, Sabeta C, Shumba W, Phahladira B, Hume S, Morton J, Rupprecht CE (2016) Efficient in vitro and in vivo activity of glyco-engineered plant-produced rabies monoclonal antibodies E559 and 62-71-3. PLoS ONE 11(7):e0159313
van de Burgwal LH, Neevel AM, Pittens CA, Osterhaus AD, Rupprecht CE, Claassen E (2017) Barriers to innovation in human rabies prophylaxis and treatment: a causal analysis of insights from key opinion leaders and literature. Zoonoses Public Health. 2017 Mar 20. https://doi.org/10.1111/zph.12352. [Epub ahead of print]
van der Laan JW, Minor P, Mahoney R, Arntzen C, Shin J, Wood D (2006) WHO informal consultation on scientific basis for regulatory evaluation of candidate human vaccines from plants, Geneva, Switzerland, 24ā25 January 2005. Vaccine 24(20):4271ā4278
van Dolleweerd CJ, Teh AY, Banyard AC, Both L, Lotter-Stark HC, Tsekoa T, Phahladira B, Shumba W, Chakauya E, Sabeta CT, Gruber C (2014) Engineering, expression in transgenic plants and characterisation of e559, a rabies virus-neutralising monoclonal antibody. J Infect Dis 210(2):200ā208
van Thiel PP, de Bie RM, Eftimov F, Tepaske R, Zaaijer HL, van Doornum GJ, Schutten M, Osterhaus AD, Majoie CB, Aronica E, Fehlner-Gardiner C, Wandeler AI, Kager PA (2009) Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs. PLoS Negl Trop Dis. 3(7):e428
Vuta V, Picard-Meyer E, Robardet E, Barboi G, Motiu R, Barbuceanu F, Vlagioiu C, Cliquet F (2016) Vaccine-induced rabies case in a cow (Bos taurus): Molecular characterisation of vaccine strain in brain tissue. Vaccine. 2016 Aug 27. pii:S0264-410X(16)30670-3
Wallace RM, Niezgoda M, Waggoner EA, Blanton JD, Radcliffe RA (2016) Serologic response in eight alpacas vaccinated by extralabel use of a large animal rabies vaccine during a public health response to a rabid alpaca in South Carolina. J Am Vet Med Assoc 249(6):678ā681
Wallace RM, Undurraga EA, Blanton JD, Cleaton J, Franka R (2017) Elimination of dog-mediated human rabies deaths by 2030: needs assessment and alternatives for progress based on dog vaccination. Front Vet Sci 10(4):9
Wang D, He X, Zhao Z, Feng Q, Lin R, Sun Y, Ding T, Xu F, Luo M, Zhan C (2015) Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons. Front Neuroanat 27(9):40
Weyer J, Kuzmin IV, Rupprecht CE, Nel LH (2008) Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes. Epidemiol Infect 136(5):670ā678
Whetstone CA, Bunn TO, Emmons RW, Wiktor TJ (1984) Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats, and one fox. J Am Vet Med Assoc 185(3):285ā288
Wilson PJ, Clark KA (2001) Postexposure rabies prophylaxis protocol for domestic animals and epidemiologic characteristics of rabies vaccination failures in Texas: 1995ā1999. J Am Vet Med Assoc 218(4):522ā525
World Health Organization (1996) Laboratory techniques in rabies, 4th ed. In: Meslin FX, Kaplan MM, Koprowski H (eds). WHO, Geneva
World Health Organization (2013) WHO expert consultation on Rabies. Second report. World Health Organ Tech Rep Ser 982:1ā139
World Health Organization Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants (2003) WHO, Geneva. Available at: http://apps.who.int/iris/bitstream/10665/42783/1/9241546271.pdf. Last accessed 29 June 2016
Wu X, Smith TG, Rupprecht CE (2011) From brain passage to cell adaptation: the road of human rabies vaccine development. Expert Rev Vaccines 10(11):1597ā1608
Yakobson B, Taylor N, Dveres N, Rozenblut S, Tov BE, Markos M, Gallon N, Homer D, Maki J (2015) Cattle rabies vaccinationāa longitudinal study of rabies antibody titres in an Israeli dairy herd. Prev Vet Med 121(1ā2):170ā175
Yang DK, Kim HH, Lee KW, Song JY (2013) The present and future of rabies vaccine in animals. Clin Exp Vaccine Res 2(1):19ā25
Yang DK, Kim HH, Choi SS, Lee SH, Cho IS (2016) A recombinant rabies virus (ERAGS) for use in a bait vaccine for swine. Clin Exp Vaccine Res. 5(2):169ā174
Yendo AC, de Costa F, Cibulski SP, Teixeira TF, Colling LC, Mastrogiovanni M, SoulĆ© S, Roehe PM, Gosmann G, Ferreira FA, Fett-Neto AG (2016) A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge. Vaccine 34(20):2305ā2311
Yusibov V, Modelska A, Steplewski K, Agadjanyan M, Weiner D, Hooper DC, Koprowski H (1997) Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci USA 94(11):5784ā5788
Yusibov V, Hooper DC, Spitsin SV, Fleysh N, Kean RB, Mikheeva T, Deka D, Karasev A, Cox S, Randall J, Koprowski H (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20(25ā26):3155ā3164
Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Human vaccines 7(3):313ā321
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rupprecht, C.E., Chikwamba, R. (2018). Rabies and Related Lyssaviruses. In: MacDonald, J. (eds) Prospects of Plant-Based Vaccines in Veterinary Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-90137-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-90137-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90136-7
Online ISBN: 978-3-319-90137-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)